S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Trends You Need to Know This Quarter
MarketBeat Week in Review – 4/8 - 4/12
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
It's almost April 15. Here's how to reduce stress and get your taxes done
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court

Foghorn Therapeutics (FHTX) SEC Filings & 10K Form

$7.42
-0.58 (-7.25%)
(As of 04/12/2024 ET)

Recent Foghorn Therapeutics SEC Filings

DateFilerForm TypeView
04/09/2024
3:41 PM
Foghorn Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2024
3:19 PM
Cavalie Fanny (Reporting)
Foghorn Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
6:09 AM
Foghorn Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2024
6:11 AM
Foghorn Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2024
6:04 AM
Foghorn Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:04 AM
Foghorn Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
6:03 AM
Foghorn Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
6:08 AM
Foghorn Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/08/2023
6:04 AM
Foghorn Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2023
6:04 AM
Foghorn Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
3:33 PM
Agresta Samuel (Reporting)
Foghorn Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2023
6:05 AM
Foghorn Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2023
6:05 AM
Foghorn Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2023
6:08 AM
Foghorn Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/28/2023
6:05 AM
Foghorn Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2023
7:10 PM
Foghorn Therapeutics (Issuer)
Mendelsohn Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
7:11 PM
Foghorn Therapeutics (Issuer)
GILL SIMBA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
7:12 PM
Foghorn Therapeutics (Issuer)
Koppel Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
7:13 PM
Biller Scott (Reporting)
Foghorn Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
7:13 PM
Foghorn Therapeutics (Issuer)
SMITH IAN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
7:14 PM
Cole Douglas G. (Reporting)
Foghorn Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
7:14 PM
Foghorn Therapeutics (Issuer)
Lynch Thomas J. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
7:15 PM
Foghorn Therapeutics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:13 PM
Foghorn Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
6:02 AM
Foghorn Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
8:22 PM
Foghorn Therapeutics (Issuer)
GOTTSCHALK ADRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2023
6:03 AM
Foghorn Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2023
6:05 AM
Foghorn Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2023
6:07 AM
Foghorn Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/24/2023
6:05 AM
Foghorn Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:FHTX) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners